Showing results (61-70 of 907) with videos related to

Sort By:
Pageof 91
Antimicrobial Agents and Chemotherapy|October 1, 1984
Clinical pharmacokinetics of aztreonam in cancer patientsP G Jones, G P Bodey, E A Swabb, et al.
Diagnostic Microbiology and Infectious Disease|April 1, 1986
Semiquantitative cultures of intravascular catheters from cancer patientsP G Jones, R L Hopfer, L Elting, et al.
Southern Medical Journal|July 1, 1989
Necrotizing gas-forming infections in cancer patientsD Z Chu, V Fainstein, G P Bodey, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patientsV Fainstein, G P Bodey, L Elting, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1981
Clinical pharmacology of moxalactam in patients with malignant diseaseE H Estey, S S Weaver, D H Ho, et al.
The Journal of Infectious Diseases|October 1, 1983
Coagulation abnormalities induced by beta-lactam antibiotics in cancer patientsV Fainstein, G P Bodey, K B McCredie, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1983
Effects of hepatic function on vancomycin clinical pharmacologyN Brown, D H Ho, K L Fong, et al.
The American Journal of Medicine|March 1, 1988
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patientsE J Anaissie, V Fainstein, G P Bodey, et al.
Archives of Internal Medicine|August 1, 1984
Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the twoE Estey, A Maksymiuk, T Smith, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1991
Single agent therapy for infections in cancer patients: a prospective randomized trial comparing three extended-spectrum cephalosporinsK V Rolston, P G Jones, V Fainstein, et al.
Pageof 91